The China Securities Regulatory Commission (CSRC) announced that its Zhejiang Securities Regulatory Bureau has opened an investigation into Zhejiang Sunflower Health Technology Co., Ltd. over suspected misleading statements in the company’s restructuring plan. Sunflower disclosed the restructuring plan on September 22, 2025. Following market doubts about the restructuring target’s actual production capacity and business model, the Zhejiang bureau conducted verifications in accordance with the law and determined that the plan is suspected of containing misleading statements. The bureau said it will handle the matter in accordance with the law after completing a comprehensive investigation, with a view to maintaining market order in mergers, acquisitions and restructuring.
China Securities Regulatory Commission 2026-01-14
China Securities Regulatory Commission’s Zhejiang Securities Regulatory Bureau opens investigation into Zhejiang Sunflower Health Technology’s restructuring plan for suspected misleading statements
The China Securities Regulatory Commission's Zhejiang Securities Regulatory Bureau is investigating Zhejiang Sunflower Health Technology Co., Ltd. for suspected misleading statements in its restructuring plan, disclosed on September 22, 2025, following market concerns about the target's production capacity and business model. The bureau aims to maintain market order in mergers, acquisitions, and restructuring through a thorough investigation.